TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer

• David J. Thomson,
• Clare Cruickshank,
• Helen Baines,
• Russell Banner,
• Matthew Beasley,
• Guy Betts,
• Helen Bulbeck,
• Frances Charlwood,
• Judith Christian,
• Matthew Clarke,
• Olly Donnelly,
• Bernadette Foran,
• Callum Gillies,
• Clare Griffin,
• Jarrod J. Homer,
• Johannes A. Langendijk,
• Lip Wai Lee,
• James Lester,
• Matthew Lowe,
• Andrew McPartlin,
• Elizabeth Miles,
• Christopher Nutting,
• Nachi Palaniappan,
• Robin Prestwich,
• James M. Price,
• Clare Roberts,
• Justin Roe,
• Ramkumar Shanmugasundaram,
• Rita Simões,
• Anna Thompson,
• Catharine West,
• Lorna Wilson,
• Jane Wolstenholme,
• Emma Hall

Affiliations

David J. Thomson

The Christie NHS Foundation Trust, Manchester, United Kingdom; Corresponding author.

Clare Cruickshank

The Institute of Cancer Research, London, United Kingdom

Helen Baines

Radiotherapy Trials QA Group (RTTQA), The Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Russell Banner

Swansea Bay University Health Board, Swansea, United Kingdom

Matthew Beasley

Bristol Cancer Institute, Bristol, United Kingdom

Guy Betts

Manchester University NHS Foundation Trust. Manchester, United Kingdom

Helen Bulbeck

Brainstrust – The Brain Cancer People, Cowes, United Kingdom

Frances Charlwood

The Christie NHS Foundation Trust, Manchester, United Kingdom

Judith Christian

Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

Matthew Clarke

The Christie NHS Foundation Trust, Manchester, United Kingdom

Olly Donnelly

Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom

Bernadette Foran

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

Callum Gillies

University College Hospitals London NHS Foundation Trust, London, United Kingdom

Clare Griffin

The Institute of Cancer Research, London, United Kingdom

Jarrod J. Homer

Manchester University NHS Foundation Trust. Manchester, United Kingdom

Johannes A. Langendijk

University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands

Lip Wai Lee

The Christie NHS Foundation Trust, Manchester, United Kingdom

James Lester

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

Matthew Lowe

The Christie NHS Foundation Trust, Manchester, United Kingdom

Andrew McPartlin

Princess Margaret Hospital, Toronto, Canada

Elizabeth Miles

Radiotherapy Trials QA Group (RTTQA), Mount Vernon Hospital, Northwood, United Kingdom

Christopher Nutting

The Institute of Cancer Research, London, United Kingdom; The Royal Marsden NHS Foundation Trust, London, United Kingdom

Nachi Palaniappan

Velindre NHS Trust, Cardiff, United Kingdom

Robin Prestwich

The Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

James M. Price

The Christie NHS Foundation Trust, Manchester, United Kingdom; The University of Manchester, Manchester, United Kingdom

Clare Roberts

The Christie NHS Foundation Trust, Manchester, United Kingdom

Justin Roe

The Royal Marsden NHS Foundation Trust, London, United Kingdom; Imperial College, London, United Kingdom

Ramkumar Shanmugasundaram

University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

Rita Simões

Radiotherapy Trials QA Group (RTTQA), Mount Vernon Hospital, Northwood, United Kingdom

Anna Thompson

University College Hospitals London NHS Foundation Trust, London, United Kingdom

Catharine West

The University of Manchester, Manchester, United Kingdom

Lorna Wilson

The Christie NHS Foundation Trust, Manchester, United Kingdom

Jane Wolstenholme

Health Economics Research Centre, University of Oxford, United Kingdom

Emma Hall

The Institute of Cancer Research, London, United Kingdom